ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $958,881 | -33.0% | 286,233 | -3.9% | 0.00% | – |
| Q4 2022 | $1,432,129 | +10.4% | 297,740 | +30.6% | 0.00% | – |
| Q3 2022 | $1,297,000 | +107.2% | 227,965 | +158.4% | 0.00% | – |
| Q2 2022 | $626,000 | -1.7% | 88,211 | -0.1% | 0.00% | – |
| Q1 2022 | $637,000 | +0.3% | 88,341 | +24.2% | 0.00% | – |
| Q4 2021 | $635,000 | -11.2% | 71,106 | +248.7% | 0.00% | – |
| Q3 2021 | $715,000 | -93.2% | 20,390 | -95.8% | 0.00% | -100.0% |
| Q2 2021 | $10,511,000 | +301.6% | 489,345 | +1055.0% | 0.00% | – |
| Q1 2021 | $2,617,000 | +46.7% | 42,366 | -0.8% | 0.00% | – |
| Q4 2020 | $1,784,000 | – | 42,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |